![A universal SARS‐CoV DNA vaccine inducing highly cross‐reactive neutralizing antibodies and T cells | EMBO Molecular Medicine A universal SARS‐CoV DNA vaccine inducing highly cross‐reactive neutralizing antibodies and T cells | EMBO Molecular Medicine](https://www.embopress.org/cms/asset/fc67d90a-65b1-4308-906e-bb9787e7f5e5/emmm.v14.10.cover.jpg)
A universal SARS‐CoV DNA vaccine inducing highly cross‐reactive neutralizing antibodies and T cells | EMBO Molecular Medicine
![EMBO Molecular Medicine. Descubierto un 'punto débil' que vuelve vulnerables a tumores resistentes a muchos fármacos - Biotech Spain EMBO Molecular Medicine. Descubierto un 'punto débil' que vuelve vulnerables a tumores resistentes a muchos fármacos - Biotech Spain](http://biotech-spain.com/files/media/image/articles/2022/07/original/22248fbxw7.jpg)
EMBO Molecular Medicine. Descubierto un 'punto débil' que vuelve vulnerables a tumores resistentes a muchos fármacos - Biotech Spain
![SARS‐CoV‐2 spike protein enhances MAP4K3/GLK‐induced ACE2 stability in COVID‐19 | EMBO Molecular Medicine SARS‐CoV‐2 spike protein enhances MAP4K3/GLK‐induced ACE2 stability in COVID‐19 | EMBO Molecular Medicine](https://www.embopress.org/cms/asset/f02661e1-a8fa-4267-8c37-96660bdb7d38/emmm.v14.9.cover.jpg)